Pharmaceuticals & Biotechnology | Pharma & Biotech Resources
Summary: Pharma IQ, a division of IQPC, is an international online community focusing on providing pharmaceutical professionals with knowledge, information and articles. We are dedicated to creating a learning environment for sharing ideas, best practices and solutions within the pharmaceutical community Through Pharma IQ, you will be able to access pharmaceutical information resources such as
- Visit Website
- RSS
- Artist: Unknown
Podcasts:
Peter Van Reusel, Business Unit Director of CRO Services at Business & Decision Life Sciences, and Albert Chau, Director of Datacision, join Helen Winsor from Pharma IQ to discuss CDISC standardisation. They debate whether there are any viable alternatives to CDISC and offer
Human factors principles and practices are playing an increasingly important role in medical device design as manufacturers recognise the range of benefits. In this interview Dr. Edmond W Israelski, Director, Human Factors, Abbott Quality and Regulatory, Abbott, joins Andrea Charles
Dr. Viraj Suvarna, Medical Director and Head of Medical Affairs at Boehringer Ingelheim, joins Andrea Charles from Pharma IQ to discuss the importance of training and re-training field operatives to report adverse drug events (ADEs) and how understanding the risk-benefit profile of your
Eric S. Langer, Managing Partner, BioPlan Associates, joins Andrea Charles from Pharma IQ, to address how the contract manufacturing sector is adapting to the changing needs of pharma and biotech, the need for access to enabling technologies and how contract manufacturing
Software quality for safety critical products has been at the centre of discussion for industry experts and the FDA. Many problems are due to software malfunctions. In this podcast, Thuy Cook, Senior Software Quality Engineer for Covidien, discusses how to manage risks for safety
With more clinical research being conducted India, there is growing pressure to address pharmacovigilance concerns. Dr. Seema Rajsingh, Head- Pharmacovigilance at Biocon, joins Andrea Charles from Pharma IQ, to discuss the main challenges the industry currently faces, setting
As part of the Pharma Leaders Today Series Dr. Keith Horspool, Vice President, Pharmaceutical Development US, Boehringer Ingelheim, speaks to Andrea Charles from Pharma IQ , about why changes are needed to current preformulation and formulation practices, strategies to reduce
Barry Tarnef, Assistant Vice President, Senior Loss Control Specialist, Chubb & Son, speaks to Andrea Charles from Pharma IQ, about current risk management trends in the supply chain for biologicals and biological agents, the challenges of implementing secure supply
Amorphous spray dried dispersions (SDDs) have emerged as a broadly applicable technology for the delivery of poorly soluble drug molecules. Methods for formulating and predicting the physical stability of these formulations are becoming better understood and more widespread. However,
Reliable, on-time delivery and distribution are vital components of a healthy supply chain. Streamlining distribution processes while improving quality and lowering costs are all key. Evaluating one’s operations is the starting point. Today Amber Scorah from Pharma IQ,
Jim Thomson, Chair, European Alliance for Safe Medicines (EAASM), joins Pharma IQ to discuss pharmaceutical counterfeiting, new EU legislation and EAASM’s recommendations.
Dr. Jörg König from the Institute for Experimental and Clinical Pharmacology and Clinical Toxicology at Friedrich-Alexander-University Erlangen-Nürnberg, Germany , speaks to Rebecca Maschke from Pharma IQ, about the analysis of transporter-mediated drug-drug interactions,
Dr. Gonzalo de Miquel, Director, Respiratory Therapy Area at Almirall R&D, speaks to Andrea Charles from Pharma IQ, about the enigma of paediatric research. In this podcast de Miquel discusses the key components of a good paediatric study design, challenges of
Janos Szebeni, Director of the Nanomedicine Research and Education Center, Bay Zoltan Foundation for Applied Research at Semmelweis University, Budapest, joins Helen Winsor Pharma IQ, to discuss developments in immunogenicity. In this exclusive interview, Szebeni talks about the
A changing regulatory landscape and increased scrutiny is an unavoidable reality within the pharmaceutical and biotech industries. A constant reanalysis of regulations is crucial for all manufacturers. Michael Burdick, Special Agent, Security and Hazardous Materials for the FAA, and
